Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone implant in alcohol use disorder
NCT07333638Phase 2Completed
- Sponsor
- Shenzhen Sciencare Medical Industries Co., Ltd.
- Start
- Apr 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone in alcohol use disorder (AUD), sponsored by Shenzhen Sciencare Medical Industries Co., Ltd.. Started Apr 2023; status: completed.
02
Drugs
naltrexone
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT07333638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07333638.